These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G; J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683 [TBL] [Abstract][Full Text] [Related]
4. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome. Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778 [TBL] [Abstract][Full Text] [Related]
6. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes. Ruan SY; Huang YT; Chu CC; Yu CJ; Hsueh PR Int J Antimicrob Agents; 2009 Sep; 34(3):236-9. PubMed ID: 19361960 [TBL] [Abstract][Full Text] [Related]
7. Candida glabrata fungemia: experience in a tertiary care center. Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662 [TBL] [Abstract][Full Text] [Related]
8. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565 [TBL] [Abstract][Full Text] [Related]
9. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. Tan TY; Tan AL; Tee NW; Ng LS; Chee CW Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263 [TBL] [Abstract][Full Text] [Related]
10. [Multicenter study of fungemia due to yeasts in Argentina]. Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A; Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683 [TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003. da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110 [TBL] [Abstract][Full Text] [Related]
13. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data. Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of candidemia in a Turkish tertiary care hospital. Bakir M; Cerikcioglu N; Barton R; Yagci A APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812 [TBL] [Abstract][Full Text] [Related]
15. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O; Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective. Colombo AL Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493 [TBL] [Abstract][Full Text] [Related]
18. Emergence of Candida tropicalis as the major cause of fungaemia in India. Mathews MS; Samuel PR; Suresh M Mycoses; 2001; 44(7-8):278-80. PubMed ID: 11714062 [TBL] [Abstract][Full Text] [Related]
19. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719 [TBL] [Abstract][Full Text] [Related]
20. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]